Altogether, these data demonstrated the potential role of STAT3 inhibitors in cancer treatment, however these molecules cannot distinguish which activation of STAT3 could be at the origin of tumor resistance as there are no pS727 specific inhibitors. Here, STAT3 is linked to neoplasm.